Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Abbott Laboratories (NYSE:ABT) recently introduced the FreeStyle Libre 3 Plus in Canada, marking an advancement in diabetes management technology with its small, sensor-based glucose monitoring system ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

AbbVie’s history stems from the late 19th century work of Chicago physician Wallace Calvin Abbott, whose small operation of ...

The sensor patch market was valued at $1.6 billion in 2022, and is estimated to reach $56.4 billion by 2032, growing at a CAGR of 43.2% from 2023 to 2032. Proactive surge in manufacturing output, ...

Abbott Laboratories just scored a confidence boost from Oppenheimer after recent CMS policy changes around heart valve repair ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Plus: Crebrid secures $500 million credit facility in partnership with Barings and John Paul Mitchell Systems relocates its ...